Mucociliary clearance: pathophysiological aspects

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Standard

Mucociliary clearance : pathophysiological aspects. / Munkholm, Mathias; Mortensen, Jann.

I: Clinical Physiology and Functional Imaging, Bind 34, Nr. 3, 05.2014, s. 171-177.

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Harvard

Munkholm, M & Mortensen, J 2014, 'Mucociliary clearance: pathophysiological aspects', Clinical Physiology and Functional Imaging, bind 34, nr. 3, s. 171-177. https://doi.org/10.1111/cpf.12085

APA

Munkholm, M., & Mortensen, J. (2014). Mucociliary clearance: pathophysiological aspects. Clinical Physiology and Functional Imaging, 34(3), 171-177. https://doi.org/10.1111/cpf.12085

Vancouver

Munkholm M, Mortensen J. Mucociliary clearance: pathophysiological aspects. Clinical Physiology and Functional Imaging. 2014 maj;34(3):171-177. https://doi.org/10.1111/cpf.12085

Author

Munkholm, Mathias ; Mortensen, Jann. / Mucociliary clearance : pathophysiological aspects. I: Clinical Physiology and Functional Imaging. 2014 ; Bind 34, Nr. 3. s. 171-177.

Bibtex

@article{8ca6bf690f9e4fb18340f4c57a7815bc,
title = "Mucociliary clearance: pathophysiological aspects",
abstract = "Mucociliary clearance has long been known to be a significant innate defence mechanism against inhaled microbes and irritants. Important knowledge has been gathered regarding the anatomy and physiology of this system, and in recent years, extensive studies of the pathophysiology related to lung diseases characterized by defective mucus clearance have resulted in a variety of therapies, which might be able to enhance clearance from the lungs. In addition, ways to study in vivo mucociliary clearance in humans have been developed. This can be used as a means to assess the effect of different pharmacological interventions on clearance rate, to study the importance of defective mucus clearance in different lung diseases or as a diagnostic tool in the work-up of patients with recurrent airway diseases. The aim of this review is to provide an overview of the anatomy, physiology, pathophysiology, and clinical aspects of mucociliary clearance and to present a clinically applicable test that can be used for in vivo assessment of mucociliary clearance in patients. In addition, the reader will be presented with a protocol for this test, which has been validated and used as a diagnostic routine tool in the work-up of patients suspected for primary ciliary dyskinesia at Rigshospitalet, Denmark for over a decade.",
keywords = "Animals, Humans, Lung, Lung Diseases, Mucociliary Clearance, Respiratory System Agents, Treatment Outcome",
author = "Mathias Munkholm and Jann Mortensen",
note = "{\textcopyright} 2013 Scandinavian Society of Clinical Physiology and Nuclear Medicine. Published by John Wiley & Sons Ltd.",
year = "2014",
month = may,
doi = "10.1111/cpf.12085",
language = "English",
volume = "34",
pages = "171--177",
journal = "Clinical Physiology and Functional Imaging",
issn = "1475-0961",
publisher = "Wiley-Blackwell",
number = "3",

}

RIS

TY - JOUR

T1 - Mucociliary clearance

T2 - pathophysiological aspects

AU - Munkholm, Mathias

AU - Mortensen, Jann

N1 - © 2013 Scandinavian Society of Clinical Physiology and Nuclear Medicine. Published by John Wiley & Sons Ltd.

PY - 2014/5

Y1 - 2014/5

N2 - Mucociliary clearance has long been known to be a significant innate defence mechanism against inhaled microbes and irritants. Important knowledge has been gathered regarding the anatomy and physiology of this system, and in recent years, extensive studies of the pathophysiology related to lung diseases characterized by defective mucus clearance have resulted in a variety of therapies, which might be able to enhance clearance from the lungs. In addition, ways to study in vivo mucociliary clearance in humans have been developed. This can be used as a means to assess the effect of different pharmacological interventions on clearance rate, to study the importance of defective mucus clearance in different lung diseases or as a diagnostic tool in the work-up of patients with recurrent airway diseases. The aim of this review is to provide an overview of the anatomy, physiology, pathophysiology, and clinical aspects of mucociliary clearance and to present a clinically applicable test that can be used for in vivo assessment of mucociliary clearance in patients. In addition, the reader will be presented with a protocol for this test, which has been validated and used as a diagnostic routine tool in the work-up of patients suspected for primary ciliary dyskinesia at Rigshospitalet, Denmark for over a decade.

AB - Mucociliary clearance has long been known to be a significant innate defence mechanism against inhaled microbes and irritants. Important knowledge has been gathered regarding the anatomy and physiology of this system, and in recent years, extensive studies of the pathophysiology related to lung diseases characterized by defective mucus clearance have resulted in a variety of therapies, which might be able to enhance clearance from the lungs. In addition, ways to study in vivo mucociliary clearance in humans have been developed. This can be used as a means to assess the effect of different pharmacological interventions on clearance rate, to study the importance of defective mucus clearance in different lung diseases or as a diagnostic tool in the work-up of patients with recurrent airway diseases. The aim of this review is to provide an overview of the anatomy, physiology, pathophysiology, and clinical aspects of mucociliary clearance and to present a clinically applicable test that can be used for in vivo assessment of mucociliary clearance in patients. In addition, the reader will be presented with a protocol for this test, which has been validated and used as a diagnostic routine tool in the work-up of patients suspected for primary ciliary dyskinesia at Rigshospitalet, Denmark for over a decade.

KW - Animals

KW - Humans

KW - Lung

KW - Lung Diseases

KW - Mucociliary Clearance

KW - Respiratory System Agents

KW - Treatment Outcome

U2 - 10.1111/cpf.12085

DO - 10.1111/cpf.12085

M3 - Review

C2 - 24119105

VL - 34

SP - 171

EP - 177

JO - Clinical Physiology and Functional Imaging

JF - Clinical Physiology and Functional Imaging

SN - 1475-0961

IS - 3

ER -

ID: 138724192